UPDATE - SEC suspends trading in Vaso Active stock
Thursday April 1, 10:54 am ET
(Adds details, stock price)
WASHINGTON, April 1 (Reuters) - U.S. securities regulators on Thursday halted trading of Vaso Active Pharmaceuticals Inc. (NasdaqSC:VAPH - News), a marketer of over-the-counter pharmaceuticals, through April 15.
The Securities and Exchange Commission questioned assertions made by the Danvers, Massachusetts-based company of an FDA approval of certain key products and regulatory consequences of the future application of their primary product, among others.
Vaso Active was not immediately available for comment.
The SEC said it questioned the accuracy of assertions made in the company's press releases, annual report, registration statement and public statements to investors.
Vaso shares closed at $7.59 Wednesday on Nasdaq.
